VI International Heart Failure Summit
Heart Failure and Pulmonary Hypertension Management in the Polypharmacy and Device Era
VIRTUAL CONFERENCE
Heart Failure Review 2021
Liotta Symposium
November 29 - December 04, 2021
​
New Heart Failure Definition & New Pathophysiologic Pathway
​
Polypharmacy 1, 2, 3, 4, 5 ,6 …. Therapies in Heart Failure
​
Cardiometabolic disease and Heart Failure (iSGLT2, GLP-1 agonist)
​
Cardiomyopathies
Focus in
Amyloidosis. Newer approaches. Early diagnosis and treatment
​
Devices and remote monitoring for HFREF & HFPEF
​
Preserved EF HF. Different Phenotypes. Newer therapies.​
New Cardiogenic Shock Guidelines
Interventional Heart Failure
​
Percutaneous Mitral Repair (Focus on Mitraclip)Aortic Stenosis: Low Flow Low gradient Low EF
Arrhythmias Control in Heart Failure
​
Multimodality imaging in HF.
Hypertrophic Cardiomyopathy (HCOM/HCM)
Pulmonary Hypertension. Different therapeutics approaches. Upfront vs sequential strategy. NOACs
Percutaneous and Durables Ventricular Assist Devices
Total Artificial Heart
Alejandro (Alex) Barbagelata, MD, FAHA, FSCAI, FICA, MSAC
Program Director
​
Dr. Barbagelata is an invasive cardiologist with Heart Failure longstanding expertise. He was past director of the Heart failure, assist devices and Transplant at University of Texas medical branch. Professor of Medicine/Cardiology Duke University School of Medicine and Board of Directors of DUCCS (Duke University Cardiovascular Society). Member of the International Speaker Bureau of the American Heart Association. He Co-direct the Heart Failure program at the Catholic University and has privileges in several centers in private practice​​
Sergio Victor Perrone, MD, FHFSA,MFACC, MSAC
Program Director
Dr. Perrone was instrumental in generating the largest Heart Failure and Transplant program in South America in the early 80s and is an opinion leader in the region. He co-direct the heart failure program at the Catholic University and direct the Heart Failure and Pulmonary Hypertension Journal. He is the advisor in Heart Failure in a lot of Institutes in Argentina and in other South American Countries
